5[1]Spostito AC,Mansur AP,Coelho OR,et al.Addition reduction in blood pressure after cholesterol-lowering treatment by statins in hypercholesterolernic patients using angiotenisn converting enzyme inhibitors.Am J Cardiol,1999,83(10):1497-1499. 被引量：1
6[2]Glorioso N,Troffa C,Filigheddu F,et al.Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.Hypertension,1999,34(6):1281-1286. 被引量：1
7[3]Su SF,Hsiao CL,Chu CW,et al.Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension.Am J Cardiol,2000,86(5):514-518. 被引量：1
8[4]Patel R,Nagueh SF,Tsybouleva N,et al.Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.Circulation,2001,104(3):317-324. 被引量：1
9[5]Tonolo G,Melis MG,Formato M,et al.Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients.Eur J Clin Invest,2000(11),30:980-987. 被引量：1
10[6]Laufs U,Fata VL,Plutzky J,et al,Upregulation of endcothelial nitric oxide synthase by HMG CoA reductace inhibitors.Circulation,1998,97:1129-1135. 被引量：1
